Relic Technologies reported a consolidated net loss of ₹102.75 lakh for the quarter ended June 30, 2026 (Q1FY27), marking a substantial improvement from the ₹368.32 lakh loss recorded in the same period of FY25. The Board of Directors approved the unaudited financial results on August 13, 2026, noting that the company has commenced revenue-generating operations through its trading activities in pharmaceuticals, nutraceuticals, wellness products, healthcare products, chemicals, and allied products.

Financial Performance

The consolidated revenue from operations stood at ₹35.49 lakh for the quarter, a sharp decline from ₹128.15 lakh in Q1FY26. This contraction in topline activity contributed to total expenses of ₹162.07 lakh, which included employee benefit expenses of ₹78.79 lakh and other expenses of ₹42.99 lakh. Consequently, the group reported a profit before tax of (₹104.21 lakh). After accounting for a net tax benefit of ₹1.46 lakh, the net loss attributable to owners of the parent was ₹64.88 lakh (standalone) and ₹102.75 lakh (consolidated).

In contrast, the standalone entity delivered a net profit of ₹21.47 lakh for the quarter, compared to a net profit of ₹9.84 lakh in Q1FY25. Standalone revenue from operations was ₹21.15 lakh, while other income contributed ₹43.00 lakh. Total standalone expenses were contained at ₹41.98 lakh, with employee benefits at ₹11.19 lakh and other expenses at ₹8.49 lakh.

What the Numbers Show

The divergence between standalone profitability and consolidated losses highlights the ongoing financial drag from subsidiaries. While Relic Technologies Limited itself generated a surplus, its subsidiaries—Relic Pharma Limited and Truhealthy Wellness Private Limited—reported a combined net loss of ₹124.22 lakh against revenues of ₹14.34 lakh for the quarter. This indicates that the group’s overall financial health remains heavily dependent on the turnaround or cost optimization within these subsidiary entities, despite the parent company’s initial success in launching new trading verticals.

Auditor Review

The unaudited standalone and consolidated financial results were reviewed by D. Kothary & Co., the statutory auditors, who issued an unmodified opinion. The review was conducted in accordance with Standard on Review Engagements (SRE) 2410 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Shareholders of Relic Technologies approved the audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026, along with several key governance and strategic resolutions at the company’s 35th Annual General Meeting (AGM) held on August 13, 2026.

The meeting, conducted via Video Conferencing or Other Audio-Visual Means (OAVM) in compliance with Ministry of Corporate Affairs (MCA) and Securities and Exchange Board of India (SEBI) circulars, featured remote e-voting and venue e-voting facilities provided by Bigshare Services Private Limited.

Governance and Director Appointments

The shareholders re-appointed Mr. Kunal Gandhi as a director, who retires by rotation under the Companies Act, 2013. The resolution received overwhelming support, with 99.997% of valid votes cast in favor.

Additionally, the company appointed Ms. Radhika Shriram as a Non-Executive Director liable to retire by rotation. This resolution passed with 84.404% of valid votes in favor, while 15.596% voted against it. Notably, remote e-voting showed significant opposition to this appointment, with only 0.012% of remote votes in favor compared to 84.392% support from venue voters.

Mr. Sachin Srivastava was appointed as a Director and subsequently as Whole Time Director and Chief Executive Officer. Both special resolutions passed with 99.999% of valid votes in favor, indicating strong shareholder confidence in the leadership transition.

Strategic Resolutions

The AGM also approved critical strategic initiatives:

• Employee Stock Option Plan (ESOP): Shareholders approved a new ESOP for the company and extended the benefits under the existing ESOP 2025 plan to employees of subsidiary companies. Both resolutions passed with 99.999% support.
• Related-Party Transactions: The company secured approval for material related-party transactions with Truhealthy Wellness Private Limited, its subsidiary. This resolution also passed with 99.999% of valid votes in favor.

Voting Participation

Participation varied across resolutions. The adoption of financial statements saw the highest engagement, with 34 members representing 49.46% of the total paid-up share capital casting votes. In contrast, the appointment of Ms. Radhika Shriram had lower participation, with only 27 members representing 11.47% of the share capital voting on this item.

Remote e-voting constituted the majority of participation across most resolutions, accounting for approximately 80% of valid votes in favor for key items such as financial statement adoption and director appointments. Venue voting contributed roughly 20% to these totals.

The scrutinizer’s report, issued by Amit Jaste & Associates, confirms that all resolutions were passed with the requisite majority as per the Companies Act, 2013 and SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.